Evidence-Based Reviews

Managing metabolic syndrome in patients with schizophrenia

Author and Disclosure Information

 

References

Melatonin

Melatonin is a naturally occurring hormone that is available over-the-counter and is frequently used to treat insomnia. Melatonin appears to have few adverse effects, is not habit-forming, and is inexpensive. It is a hormone produced primarily by the pineal gland, although it is also produced by many other cell types, including the skin, gut, bone marrow, thymus, and retina.21,22 Melatonin is a highly conserved essential hormone23 that acts via both G protein-coupled membrane bound receptors and nuclear receptors.23-25 Its ability to function both intra- and extracellularly implies it has an essential role in maintaining homeostatic mechanisms. Melatonin’s putative mechanism of action may derive from its effects on circadian rhythms, which in turn affect systolic blood pressure, glycemic control, and oxidative stress. In rodents, pinealectomy led to the rapid development of hypertension and metabolic syndrome. Daily administration of melatonin26 in these animals restored metabolism by decreasing abdominal fat and plasma leptin levels. These studies suggest that melatonin plays a central role in metabolism.

A recent study of patients with first-episode psychosis (n = 48) examined the effects of melatonin (3 mg/d) as an add-on treatment to olanzapine vs placebo.27 Compared with those in the placebo group, participants in the melatonin group experienced a statistically significant decrease in body weight, BMI, waist circumference, and triglyceride levels.27 In another study, the melatonin receptor agonist ramelteon was used in conjunction with SGAs.28 Augmentation with ramelteon led to significantly lower rises in total cholesterol levels compared with placebo.28

When recommending melatonin for a patient with schizophrenia, suggest that he/she begin by taking a starting dose of 3 mg nightly.

Weighing the options

Which medication to prescribe for a patient such as Mr. N would depend on the patient’s specific complaint/health target.

Weight gain or diabetes. If the patient’s primary concerns are avoiding weight gain or the development of diabetes, metformin is an excellent starting point.

Continue to: Migraines or desire to lose weight

Pages

Recommended Reading

Negative symptoms of schizophrenia: An update
MDedge Psychiatry
Mental illness tied to increased mortality in COVID-19
MDedge Psychiatry
Deep brain stimulation ‘promising’ in severe schizophrenia
MDedge Psychiatry
Repurposing cardiovascular drugs for serious mental illness
MDedge Psychiatry
Conquering the stigma of getting mental health care
MDedge Psychiatry
Melancholic, psychotic depression may protect against ECT cognitive effects
MDedge Psychiatry
Distinguish ‘sleepiness’ from ‘fatigue’ to help diagnose hypersomnia
MDedge Psychiatry
Use long-acting second-generation antipsychotics ‘as early as possible’ in psychosis
MDedge Psychiatry
Inattention to heightened CV risk common theme in clozapine deaths teaser
MDedge Psychiatry
Food preservative for early psychosis: Final word?
MDedge Psychiatry